Rapid Readouts

onclive rapid readouts logo

OncLive presents Rapid Readouts. In each video, leading experts in their field present slides and posters from annual oncology conferences, symposiums, and meetings, highlighting the everchanging landscape of treatment choices for patient management.

Select Conference:
World Conference on Lung Cancer
AACR
ASH
SABCS
ASCO
ESMO
World GI
Select Year:
2021
2020

Phase 1/2 Study of Mobocertinib in mNSCLC With EGFR Exon 20 Insertions: EXCLAIM and Platinum-Pretreated Patients Cohorts

February 19th, 2021

Rapid Readouts: A Global Study of Advanced Dosimetry in the Treatment of HCC With Y 90 Glass Microspheres

May 12th, 2021

Rapid Readouts: Results from the Phase 3 CHRONOS-3 Trial for Relapsed iNHL

May 7th, 2021

Rapid Readouts: Phase 2 Trial of Pevonedistat Plus Azacitidine Versus Azacitidine in Higher-Risk MDS/CMML or LB AML

April 28th, 2021

Rapid Readouts: Phase 2 CodeBreak 100 Trial

March 4th, 2021

Rapid Readouts: Final Analysis Results From the Phase 3 TITAN Study

March 3rd, 2021

Rapid Readouts: Postoperative Chemotherapy Use and Outcomes from ADAURA

February 19th, 2021

Rapid Readouts: Patient-Reported Outcomes from ADAURA

February 19th, 2021

Rapid Readouts: Phase 1/2 Study of Epcoritamab in R/R B-cell NHL

January 28th, 2021

Rapid Readouts: Phase 2 JULIET Trial

January 26th, 2021

Rapid Readouts: Larotrectinib in Advanced TRK Fusion Thyroid Cancer

January 19th, 2021

Rapid Readouts: Efficacy of Novel Targeted Therapies Post-MURANO Study

January 18th, 2021

Rapid Readouts: The Phase 1/2 ANCHOR Trial for Melphalan Flufenamide in Relapsed/Refractory Multiple Myeloma

January 18th, 2021

Rapid Readouts: Phase 2 Study of Navitoclax in High-Risk Myelofibrosis

January 15th, 2021

Rapid Readouts: Results from the Phase 3 ANDROMEDA Study

January 14th, 2021

Rapid Readouts: Five-Year Analysis of MURANO Study

December 23rd, 2020

Rapid Readouts: Updated Results From KX-ORAX-001 Study

December 23rd, 2020

Rapid Readouts: Phase 1b/2 CARTITUDE-1 Study

December 23rd, 2020

Rapid Readouts: Updated Results From DESTINY-Breast01

December 23rd, 2020

Rapid Readouts: Momelotinib's Spleen, Symptom, and Anemia Efficacy

December 10th, 2020

Rapid Readouts: Long-Term Results from SIMPLIFY-1 and SIMPLIFY-2

December 10th, 2020

Rapid Readouts: Phase 3 VIALE-A Study

December 3rd, 2020

Rapid Readouts: Phase 1/2 KRYSTAL-1 Trial

November 18th, 2020

Rapids Readouts: Phase 3 CheckMate 238 Trial

October 30th, 2020

Rapid Readouts: TROPHY-U-01 Cohort 1 Final Results

October 14th, 2020

Rapid Readouts: Phase 3 HERO Trial

October 8th, 2020

Rapid Readouts: Phase 3 CheckMate 9ER Trial

October 7th, 2020

Rapid Readouts: Phase 3 ASCENT Study

October 5th, 2020

Rapid Readouts: Phase III PAOLA-1/ENGOT-ov25 Trial

August 24th, 2020

Rapid Readouts: Phase 1/2 Study Results of Liposomal Irinotecan and FOLFOX

July 17th, 2020

Rapid Readouts: Initial Results of the Phase III BOSTON Study

June 29th, 2020

Rapid Readouts: The SOLO2 / ENGOT Ov-21 Trial

June 25th, 2020

Rapid Readouts: Three-Year Update From CheckMate 227, Part 1

June 23rd, 2020

Rapid Readouts: Final Analysis of KEYNOTE-189

June 23rd, 2020

Rapid Readouts: Update of CARTITUDE-1

June 23rd, 2020

Rapid Readouts: The TIVO-3 Study of Tivozanib in Metastatic Renal Cell Carcinoma

June 19th, 2020

Rapid Readouts: CheckMate 9LA

June 16th, 2020

Rapid Readouts: JAVELIN Bladder 100 Phase III Interim Analysis

June 16th, 2020